Fresenius Medical Care AG
DUS:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG
DUS:FME
|
DE |
|
Minaean SP Construction Corp
F:NJA
|
CA |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
B
|
Broadcom Inc
XMUN:1YD
|
US |
|
B
|
Beazer Homes USA Inc
F:BE4A
|
US |
Wall St Price Targets
FME Price Targets Summary
Fresenius Medical Care AG
According to Wall Street analysts, the average 1-year price target for FME is 45.22 EUR with a low forecast of 22.36 EUR and a high forecast of 64.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FME's stock price target?
Price Target
45.22
EUR
According to Wall Street analysts, the average 1-year price target for FME is 45.22 EUR with a low forecast of 22.36 EUR and a high forecast of 64.95 EUR.
What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 5 years is 3%.
What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 5 years is 10%.
What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 5 years is 14%.
